We are live on ! Find out more
WS

Wela Strategies Portfolio holdings

AUM $264M
1-Year Est. Return 16.32%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+16.32%
3 Year Est. Return
+51.28%
5 Year Est. Return
+48.35%
10 Year Est. Return
AUM
$232M
AUM Growth
+$2.63M
Cap. Flow
+$32.5M
Cap. Flow %
14.01%
Top 10 Hldgs %
77.49%
Holding
76
New
24
Increased
19
Reduced
10
Closed
23

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.4M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$12.4M
3
DE icon
Deere & Co
DE
+$10.8M
4
GEV icon
GE Vernova
GEV
+$10.2M
5
NKE icon
Nike
NKE
+$9.5M

Sector Composition

Rank Sector Weight
1 Financials 26.27%
2 Consumer Discretionary 7.94%
3 Industrials 4.21%
4 Healthcare 1.08%
5 Energy 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
26
ConocoPhillips
COP
$147B
$635K 0.27%
+4,383
New +$465K
DOV icon
27
Dover
DOV
$28.3B
$629K 0.27%
+10,617
New +$2.08M
GILD icon
28
Gilead Sciences
GILD
$166B
$617K 0.27%
6,675
+816
+14% +$73.5K
NVO
29
Novo Nordisk
NVO
$209B
$590K 0.25%
+2,357
New +$255K
VGT icon
30
Vanguard Information Technology ETF
VGT
$148B
$584K 0.25%
+16,000
New +$1.23M
AXP icon
31
American Express
AXP
$228B
$578K 0.25%
1,947
+251
+15% +$72.1K
CMI icon
32
Cummins
CMI
$88.3B
$577K 0.25%
1,657
+221
+15% +$77.6K
EMB icon
33
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$571K 0.25%
+1,347
New +$123K
HON icon
34
Honeywell
HON
$77.3B
$560K 0.24%
2,628
+647
+33% +$135K
JNJ icon
35
Johnson & Johnson
JNJ
$630B
$503K 0.22%
3,475
+525
+18% +$81.4K
GGG icon
36
Graco
GGG
$13.5B
$501K 0.22%
+3,262
New +$283K
AGG icon
37
iShares Core US Aggregate Bond ETF
AGG
$137B
$473K 0.2%
+60,170
New +$5.93M
HIO
38
Western Asset High Income Opportunity Fund
HIO
$340M
$472K 0.2%
120,196
+2,304
+2% +$9.16K
IGD
39
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$521M
$455K 0.2%
83,935
+1,983
+2% +$11K
VLO icon
40
Valero Energy
VLO
$90.4B
$453K 0.2%
+10,085
New +$1.35M
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$135B
$451K 0.19%
+46,113
New +$21.4M
IVV icon
42
iShares Core S&P 500 ETF
IVV
$904B
$439K 0.19%
41,991
-53,183
-56% -$31.5M
CSX icon
43
CSX Corp
CSX
$93.3B
$433K 0.19%
+1,027
New +$35.2K
EXC icon
44
Exelon
EXC
$46.1B
$413K 0.18%
11,093
-7,609
-41% -$295K
GEHC icon
45
GE HealthCare
GEHC
$33.1B
$345K 0.15%
+5,650
New +$480K
KO icon
46
Coca-Cola
KO
$376B
$292K 0.13%
4,691
+147
+3% +$9.6K
VXF icon
47
Vanguard Extended Market ETF
VXF
$31.8B
$282K 0.12%
1,486
-49
-3% -$9.45K
SO icon
48
Southern Company
SO
$105B
$256K 0.11%
3,115
-448
-13% -$39.3K
ADBE icon
49
Adobe
ADBE
$108B
$235K 0.1%
+1,239
New +$613K
BIV icon
50
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$232K 0.1%
10,173
-23,511
-70% -$1.79M

Similar funds

Wela Strategies's Q4 2024 Portfolio in Review

As of Q4 2024, Wela Strategies held 76 positions worth $232M, up 1.1% from $229M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Wela Strategies deployed $32.5M of net new capital in Q4 2024, opening 24 new positions and adding to 19 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 46,113 shares worth $451K.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 0.29% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $31.5M trimmed.

  • Wela Strategies's largest Q4 2024 buy was Vertex Pharmaceuticals: 46,113 shares worth $451K.
  • Wela Strategies added most to Deere & Co in Q4 2024, an estimated $10.8M increase.
  • Wela Strategies's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $31.5M.
  • Wela Strategies fully exited Vanguard Total Bond Market in Q4 2024, selling an estimated $12.2M.
  • Wela Strategies's ten largest holdings make up 77% of its $232M portfolio in Q4 2024.
  • Wela Strategies opened 24 new positions and closed 23 in Q4 2024.
  • Wela Strategies's portfolio value rose 1.1% quarter-over-quarter to $232M.

Based on Wela Strategies's 13F filing for Q4 2024, filed 13 Jan 2025.